人类疾病中的蛋白质稳定签名
Christine M Lim1, Michele Vendruscolo1
1Centre for Misfolding Diseases, Yusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, United Kingdom.
PLoS computational biology
|June 17, 2025
概括
这项研究定义了蛋白质稳定性特征,揭示了32种疾病中蛋白质稳定性网络变化的独特模式. 这些签名有助于区分疾病和跟踪疾病的进展,为疾病机制提供了新的见解.
科学领域:
- 分子生物学分子生物学
- 系统生物学 系统生物学
- 疾病的病原发生 疾病的病原发生
背景情况:
- 蛋白质稳态 (蛋白质稳态) 网络对于维持细胞功能至关重要.
- 虽然蛋白质稳定网络已被绘制,但其在疾病中的作用尚未完全理解.
- 了解疾病中的蛋白质稳定性障碍是表征疾病机制的关键.
研究的目的:
- 定义与疾病相关的蛋白质稳定网络变化的特征模式的蛋白质稳定签名.
- 在各种人类疾病中进行大规模的泛疾病分析.
- 研究蛋白质稳定性破坏的时间演变和疾病特异性.
主要方法:
- 进行了32种人类疾病的泛疾病分析,涵盖7种疾病类型.
- 确定了特定于疾病状态的独特蛋白质稳定性扰动.
- 在疾病进展过程中分析了蛋白质稳定特征的时间动态.
主要成果:
- 在各种疾病中定义了独特的蛋白质稳定特征.
- 发现了区分疾病类型的独特特征,突出了各种蛋白质稳定机制.
- 观察到与疾病进展相关的蛋白质稳定性破坏的变化.
- 表明吸烟会像疾病一样损害蛋白质静止,可能使个人易患疾病.
结论:
- 蛋白质稳定签名为研究人类疾病提供了新的视角.
- 标志性蛋白质稳定性障碍可以阐明疾病机制和进展.
- 了解像吸烟这样的环境因素对蛋白质静止的影响,对于预防疾病至关重要.
相关概念视频
Regulation of the Unfolded Protein Response
2.6K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.6K
Notch Signaling Pathway
4.5K
The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
4.5K
Regulated Protein Degradation
2.6K
2.6K
The Proteasome
1.2K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.2K
The Unfolded Protein Response
5.1K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
5.1K
Overview of Protein Metabolism
1.9K
Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
1.9K


